Evaluation of the Effect of Chelating Arms and Carrier Agents on t he Radiotoxicity of TAT Agents.

Farzipour, Soghra; Shaghaghi, Zahra; Raeispour, Marziyeh; Alvandi, Maryam; Jalali, Fatemeh; Yazdi, Amirhossein

Farzipour, Soghra; Shaghaghi, Zahra; Raeispour, Marziyeh; Alvandi, Maryam; Jalali, Fatemeh; Yazdi, Amirhossein.

Afiliação

Farzipour S; Department of Cardiology, Cardiovascular Diseases Research Center, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Shaghaghi Z; Department of Pharmaceutical Biotechnology, School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran.
Raeispour M; Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Alvandi M; Department of Nuclear Medicine and Molecular Imaging, Clinical Development Research Unit of Farshchian Heart Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Jalali F; Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Yazdi A; Department of Nuclear Medicine and Molecular Imaging, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

Curr Radiopharm ; 16(1): 2-22, 2023.

Article em En | MEDLINE | ID: mdl-35538822

Assuntos

Neoplasias; Compostos Radiofarmacêuticos; Humanos; Compostos Radiofarmacêuticos/farmacologia; Compostos Radiofarmacêuticos/uso terapêutico; Radioisótopos/uso terapêutico; Neoplasias/tratamento farmacológico; Partículas alfa/uso terapêutico

Palavras-chave

Targeted alpha therapy; carrier; chelator; dosimetry; radiobiology; radiotoxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Radiofarmacêuticos / Neoplasias Limite: Humans Idioma: En Revista: Curr Radiopharm Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google